Ally Bridge Group

Ally Bridge Group is a healthcare-focused private investment group founded in 2013, with operations in Hong Kong and the United States. The firm specializes in venture and growth capital, buyout, and hedge fund investing, primarily targeting life sciences companies and innovative medical technologies. With a commitment to bridging the gap between groundbreaking healthcare innovations and global markets, Ally Bridge Group invests in both private and public equity across various sectors, including medical devices and biopharmaceuticals. By leveraging its extensive expertise and network, the firm aims to support the development and growth of its portfolio companies, focusing on transformative solutions that address significant unmet medical needs.

Slanix Alex

Portfolio Manager and President, Public Equity

Tinnie Chau

Vice President

Charles Chon

Managing Director

Paresh Kumar

Vice President

David Nikodem

Managing Director

Sebastian Paquette

Principal, Private Equity

Plachtyna, Steven

Vice President

Reese Yeh

Managing Director

Frank Yu

Founder and CEO

Steven Plachtyna

Vice President, Private Equity

Past deals in Assisted Living

Kandu Health

Venture Round in 2025
Kandu is a tech-enabled healthcare company focused on enhancing the quality of life for stroke survivors and their families. The company specializes in stroke recovery training, stroke detection research, and educational services. It provides remote clinical support through a dedicated app, delivering personalized information, resources, and guidance tailored to the needs of each user. This approach empowers stroke survivors to take control of their recovery and adjust to life after a stroke.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.